Kindly consult your healthcare professional prior to taking Brufen®
Kindly refer to the leaflet to know more about Brufen®
You can report any adverse event with Brufen® on the below email epdpvgulf@abbott.com
Other Brufen® formulations are available in the market.
Brufen is available in different formulations for adults and children.
Brufen Rapid is indicated for children aged from12 years or above1
Brufen® Syrup is indicated from 3 months and above2
*vs. normal capsule
References:
1. Brufen Rapid leaflet
2. Pediatric Syrup leaflet
3. SAANO V, PARONEN P, PEURA P, et al. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers. International Journal of Clinical Pharmacology, Therapy and Toxicology 1991; Vol. 385-381:(10) 29
4. Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin pharmacokonet 154-101 :(2) 34 ;1998
5. Walson PD, Galletta G, Braden NJ, et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther. 1989 Jul;17-9:(1)46.
Abbott Laboratories GmbH Dubai Airport Free Zone (DAFZA) Building 5W, Block A 8th floor, Office 801 Dubai, UAE Tel: +971 4 2132700
© 2017 Abbott Laboratories Inc. Abbott Park, Illinois, USA. All Rights Reserved. Please read the Legal Notice for further details.
Unless otherwise specified, all product and service names appearing in this internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. All other trademarks are the property of their respective owners.
The information contained in this website is intended solely for users domiciled in the United Arab Emirates as it only features Abbott Laboratories pharmaceutical products available for purchase in the United Arab Emirates. By accessing and viewing this Website, you warrant that you are domiciled in the United Arab Emirates. If you are not domiciled in the United Arab Emirates you are requested to exit this website
GLF2304294-3 9FIWYCNJ-271124 Expiry 30/05/2025
